Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 22
- Labeller names
- 4
- Live patents
- 0
- Shortage listings
- 5
- Countries
- 0
Alert
Drug shortage listings
5| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01) | Current | Unavailable | 12 Oct 202216 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01) | Current | Unavailable | 12 Oct 202216 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01) | Current | Unavailable | 12 Oct 202216 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01) | Current | Unavailable | 12 Oct 202216 Sept 2026 |
| Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate TabletPsychiatry | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01) | Current | Unavailable | 12 Oct 202216 Sept 2026 |
Catalogue
Drug listings by form and route
2222 active NDC listings: 22 human prescription drug. By marketing category: ANDA 21, UNAPPROVED DRUG OTHER 1.
| Dosage form | NDCs |
|---|---|
| tablet, extended release | 12 |
| tablet | 8 |
| injection, solution | 1 |
| powder, for suspension | 1 |
| Route | NDCs |
|---|---|
| oral | 21 |
| intravenous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| oryza pharmaceuticals inc. | 10 |
| oryza pharmaceuticals inc. | 6 |
| oryza pharmaceuticals, inc | 4 |
| oryza pharmaceuticals, inc. | 2 |
Catalogue
Marketed products
22| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Carbamazepine ER | Carbamazepine | tablet, extended release, oral | 72516-020ANDA |
| Carbamazepine ER | Carbamazepine | tablet, extended release, oral | 72516-021ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-011ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-012ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-013ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-014ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-015ANDA |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet, oral | 72516-016ANDA |
| Metoprolol Succinate | Metoprolol Succinate | tablet, extended release, oral | 72516-030ANDA |
| Metoprolol Succinate | Metoprolol Succinate | tablet, extended release, oral | 72516-031ANDA |
| Metoprolol Succinate | Metoprolol Succinate | tablet, extended release, oral | 72516-032ANDA |
| Metoprolol Succinate | Metoprolol Succinate | tablet, extended release, oral | 72516-033ANDA |
| Metoprolol succinate | Metoprolol succinate | tablet, extended release, oral | 72516-025ANDA |
| Metoprolol succinate | Metoprolol succinate | tablet, extended release, oral | 72516-026ANDA |
| Metoprolol succinate | Metoprolol succinate | tablet, extended release, oral | 72516-027ANDA |
| Metoprolol succinate | Metoprolol succinate | tablet, extended release, oral | 72516-028ANDA |
| Oseltamivir Phosphate for Oral Suspension | Oseltamivir Phosphate | powder, for suspension, oral | 72516-029ANDA |
| Papaverine Hydrochloride | Papaverine Hydrochloride | injection, solution, intravenous | 72516-024UNAPPROVED DRUG OTHER |
| Ticagrelor | Ticagrelor | tablet, oral | 72516-017ANDA |
| Ticagrelor | Ticagrelor | tablet, oral | 72516-018ANDA |
| buPropion Hydrochloride XL | bupropion hydrochloride | tablet, extended release, oral | 72516-035ANDA |
| buPropion Hydrochloride XL | bupropion hydrochloride | tablet, extended release, oral | 72516-036ANDA |
Compare
Other companies listing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Teva Pharmaceutical Industries Ltd.6 sites · 668 NDC
- Epic Laboratories, LLC3 sites · 209 NDC
- Aurolife Pharma LLC3 sites · 70 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Lannett Company, LLC1 site · 190 NDC
- Elite Laboratories, Inc.1 site · 54 NDC
- NorthStar RxLLC0 sites · 302 NDC
Enquiry
Common questions
- Is Oryza Pharmaceuticals, Inc. FDA approved?
- Oryza Pharmaceuticals, Inc. holds no registered establishment of its own; 22 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Oryza Pharmaceuticals, Inc. make?
- 22 products are listed under Oryza Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, extended release; tablet; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any Oryza Pharmaceuticals, Inc. products in shortage?
- 5 presentations are currently listed in the FDA drug shortage database under Oryza Pharmaceuticals, Inc., covering Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.